Mar 29 2018
Auris’s Monarch Platform was featured in MedGadget, an online publication that covers the latest news in medical technology around the world, in an article titled “Monarch Robotic Endoscopy for Spotting Small, Deep-Seated Lung Nodules Cleared by FDA.”
The article covers introduction of the Monarch Platform and mentions that the technology was cleared by the FDA. With the Monarch Platform, Auris will leverage the power of flexible robotics to transform endoscopy, the use of small cameras and tools to enter the body through its natural openings. With bronchoscopy as its first application, the Monarch Platform could help physicians reach into the periphery of the lungs. This capability would give the physician access to lung nodules that can often be missed. According to the article, the potential for Auris’s technology could include delivery of therapy in addition to helping with diagnosis. The article also notes the similarities between the Monarch Platforms controls and video game controllers and gives some background on how the technology works.
Excerpt from the article: "The company believes that being able to reach into the periphery of the lungs can help to spot nodules that are typically missed these days."Read More about Auris Health on MedGadget
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.